BioGaia
129.50 SEK
-1.15 %
Less than 1K followers
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-1.15 %
+7.38 %
+24.88 %
+21.94 %
+24.40 %
+23.33 %
+27.21 %
+59.88 %
+1,723.09 %
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.
Read moreMarket cap
13.1B SEK
Turnover
14.15M SEK
Revenue
1.54B
EBIT %
26.82 %
P/E
39.36
Dividend yield-%
3.09 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
17/7
2026
Interim report Q2'26
22/10
2026
Interim report Q3'26
All
Webcasts
Press releases
ShowingAll content types
Kommuniké från årsstämma i BioGaia
BioGaia, Audiocast, Q1'26
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
